Celgene (NASDAQ:CELG) reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $2.86 on revenue of $4.40B. Analysts polled by forecast EPS of $2.63 on revenue of $4.24B. That compared to EPS of $2.16 on revenue of $3.81B in the same period a year earlier. The company had reported EPS of $2.55 on revenue of $4.03B in the previous quarter.
Celgene shares gained 1.03% to trade at $93.95 in pre-market trade following the report.
Celgene follows other major Healthcare sector earnings this month
On July 16, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.
Pfizer earnings beat analysts' expectations on Monday, with second quarter EPS of $0.8 on revenue of $13.26B. analysts expected EPS of $0.75 on revenue of $13.41B
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
